JPMorgan Chase & Co. Buys 417,161 Shares of Apogee Therapeutics Inc. $APGE
JPMorgan Chase & Co. increased its stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 57.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,137,731 shares of the company's stock after acquiring an additional 417,161...